Agios Pharmaceuticals (AGIO) Stock Price, Quote, News & History | Benzinga

Agios Pharmaceuticals Inc (AGIO) Stock Price, Quote, News & History

AGIONASDAQ

Trade with Public

Trade with Public

$34.21

At close: Aug 13, 5:00 PM EST

$34.21

N/A

After Hours: 4:00 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

-

Volume / Avg.

0 / 1.12M

Day Range

- - -

52 Wk Range

22.24 - 46.00

Market Cap

$2.04B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

55

Short Interest

11.58%

Days to Cover

5.14

Recent Agios Pharmaceuticals, Inc. News

Agios Reports Neutral Sickle Cell Data, Decides To Stop Development

Agios Pharmaceuticals stops tebapivat development in sickle cell disease after Phase 2 study fails to prove meaningful differentiation.

Vandana Singh

Danaher Posts Q2 Results, Joins Calix, Equifax And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session

US stock futures up, Nasdaq 100 gains 1%. Danaher Corp (DHR) shares fall 10.1% in pre-market trading. Other stocks also decline.

Avi Kapoor

Why Is Agios Pharma Stock Soaring Tuesday?

Agios Pharma (AGIO) stock spikes 15% as FDA grants Priority Review for sickle cell disease drug mitapivat. Details here.

Vandana Singh

DigitalOcean, Agios Pharmaceuticals, Kingsoft Cloud And Other Big Stocks Moving Higher On Tuesday

US stocks were mixed, Nasdaq fell 1%. DigitalOcean shares rose after strong revenue growth and earnings guidance. Other big gainers include CRNX, MAAS, and AGIO.

Avi Kapoor

US Stocks Mixed; Cleveland-Cliffs Shares Fall After Q1 Results

US stocks mixed, energy shares climb. Cleveland-Cliffs falls 6% after reporting Q1 results. Enveric Biosciences, Fitness Champs, Clearmind Medicine surge.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-360.60M

Investing Cash Flow (TTM)

367.15M

Financing Cash Flow (TTM)

12.22M

Free Cash Flow (TTM)

-390.25M

Capital Expenditure (TTM)

-29.66M

Net Change in Cash (TTM)

18.78M

Analyst Trends and Forecast

1

May

1

1

Jun

6

Jul

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.3

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.46B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

20.42

PB Ratio (TTM)

1.99

Earnings Yield % (TTM)

-20.49%

Earnings Yield % (FWD)

-17.33%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$17.19

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$99.65M

Debt to Equity

0.03

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

-

Volume / Avg.

0 / 1.12M

Day Range

- - -

52 Wk Range

22.24 - 46.00

Market Cap

$2.04B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

55

Short Interest

11.58%

Days to Cover

5.14

About

Sector

Health Care

Industry

Biotechnology

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially tra...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Agios Pharmaceuticals (AGIO) stock?

A

You can purchase shares of Agios Pharmaceuticals (NASDAQ:AGIO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Agios Pharmaceuticals (AGIO) competitors?

A

Other companies in Agios Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Agios Pharmaceuticals (AGIO) stock?

A

Agios Pharmaceuticals has a consensus price target of $45.25.

Q

What is the current price for Agios Pharmaceuticals (AGIO)?

A

The stock price for Agios Pharmaceuticals (NASDAQ: AGIO) is $34.21 last updated August 12, 2026 at 4:00 PM EDT.

Q

Does Agios Pharmaceuticals (AGIO) pay a dividend?

A

There are no upcoming dividends for Agios Pharmaceuticals.

Q

When is Agios Pharmaceuticals (NASDAQ:AGIO) reporting earnings?

A

Agios Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Agios Pharmaceuticals (AGIO) going to split?

A

There is no upcoming split for Agios Pharmaceuticals.

Q

What sector and industry does Agios Pharmaceuticals (AGIO) operate in?

A

Agios Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.